Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Loa Loa (eye worm) | runx1 | 0.0056 | 0.126 | 0.126 |
Echinococcus multilocularis | Protein lozenge | 0.0056 | 0.126 | 0.126 |
Schistosoma mansoni | hypothetical protein | 0.0037 | 0.0629 | 0.0629 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0054 | 0.1172 | 0.1172 |
Schistosoma mansoni | hypothetical protein | 0.033 | 1 | 1 |
Onchocerca volvulus | Protein cereblon homolog | 0.033 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0054 | 0.1172 | 0.1172 |
Schistosoma mansoni | lozenge | 0.0056 | 0.126 | 0.126 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0054 | 0.1172 | 0.1172 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0054 | 0.1172 | 0.1172 |
Loa Loa (eye worm) | hypothetical protein | 0.033 | 1 | 1 |
Echinococcus multilocularis | protein cereblon | 0.033 | 1 | 1 |
Echinococcus granulosus | protein cereblon | 0.033 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0037 | 0.0629 | 0.0629 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0037 | 0.0629 | 0.0629 |
Entamoeba histolytica | hypothetical protein, conserved | 0.033 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
GC50 (functional) | = 7.8 uM | The growth inhibitory concentration of compound was determined by logistic regression of viable cell number on Human leukemia 60 cells | ChEMBL. | 8765525 |
TC50 (ADMET) | = 10.3 uM | The toxic concentration of compound was determined by diester concentration in Human leukemia 60 cells. | ChEMBL. | 8765525 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.